Carlos U. Corvera
Papers
3
Total Citations
13
H-Index
3
About
Dr. Carlos U. Corvera is a pioneering hepatopancreatobiliary (HPB) surgeon whose work bridges advanced minimally invasive techniques and personalized oncology. His research centers on two transformative frontiers: the adoption of robotic and laparoscopic surgery for complex pancreatic and foregut tumors, and the development of patient-specific therapies for aggressive liver cancers. Dr. Corvera’s landmark 2025 study on minimally invasive distal pancreatectomy (MIDP) critically examines whether this approach has become the standard of care in the U.S., analyzing temporal trends in utilization and outcomes—a contribution that has already garnered 6 citations and shapes national surgical guidelines. He has also demonstrated technical virtuosity with robotic-assisted endoluminal resection of gastroesophageal junction leiomyomas, achieving transoral specimen extraction. In the realm of precision medicine, his 2020 work on patient-derived organoids for intrahepatic cholangiocarcinoma (ICC) offers a groundbreaking platform for personalized drug screening, addressing the urgent need for novel therapies in a disease with median survival under one year. With a career defined by innovation in both the operating room and the laboratory, Dr. Corvera is redefining standards of care for some of the most challenging malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3